Status:
COMPLETED
C Difficile Near-patient Diagnostics
Lead Sponsor:
University of Calgary
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Alberta Health services
Conditions:
Clostridium Difficile
Eligibility:
All Genders
Phase:
NA
Brief Summary
The investigators will conduct a two-period, two-intervention, cluster randomized crossover (CRXO) designed study at Foothills Hospital in Calgary, Alberta. Each cluster (hospital ward) will receive e...
Detailed Description
Antimicrobial resistance (AMR) has been designated as a major priority by the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC) and the Public Health Agency of Canada (...
Eligibility Criteria
Inclusion
- Patients located on inpatient wards for whom C. difficile test is ordered at Foothills Medical Center. Usually defined by having 3 or more loose bowel movements in a 24 hour period.
Exclusion
- No diagnostics for C. difficile requested. Inpatient at a different facility. All outpatients.
Key Trial Info
Start Date :
January 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2020
Estimated Enrollment :
3816 Patients enrolled
Trial Details
Trial ID
NCT03857464
Start Date
January 15 2019
End Date
May 31 2020
Last Update
May 9 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Calgary Laboratory Services
Calgary, Alberta, Canada, T2L 2K8
2
Foothills Medical Center Rapid Response Laboratory
Calgary, Alberta, Canada, T2L 2K8